ES2788140B2 - Terapia de fotobiomodulacion distribuida, sistema y metodo - Google Patents
Terapia de fotobiomodulacion distribuida, sistema y metodo Download PDFInfo
- Publication number
- ES2788140B2 ES2788140B2 ES202090046A ES202090046A ES2788140B2 ES 2788140 B2 ES2788140 B2 ES 2788140B2 ES 202090046 A ES202090046 A ES 202090046A ES 202090046 A ES202090046 A ES 202090046A ES 2788140 B2 ES2788140 B2 ES 2788140B2
- Authority
- ES
- Spain
- Prior art keywords
- led
- pbt
- pad
- leds
- current
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims description 114
- 238000002560 therapeutic procedure Methods 0.000 title description 73
- 238000011282 treatment Methods 0.000 claims description 171
- 230000006854 communication Effects 0.000 claims description 160
- 238000004891 communication Methods 0.000 claims description 160
- 238000004422 calculation algorithm Methods 0.000 claims description 56
- 230000008569 process Effects 0.000 claims description 52
- 230000005670 electromagnetic radiation Effects 0.000 claims description 23
- 230000005855 radiation Effects 0.000 claims description 17
- 238000001126 phototherapy Methods 0.000 claims description 10
- 239000004020 conductor Substances 0.000 claims description 8
- 230000006870 function Effects 0.000 description 170
- 239000010410 layer Substances 0.000 description 107
- 230000015572 biosynthetic process Effects 0.000 description 72
- 238000003786 synthesis reaction Methods 0.000 description 71
- 210000001519 tissue Anatomy 0.000 description 51
- 238000010586 diagram Methods 0.000 description 31
- 238000004519 manufacturing process Methods 0.000 description 31
- 238000012546 transfer Methods 0.000 description 31
- 238000001228 spectrum Methods 0.000 description 30
- 230000005291 magnetic effect Effects 0.000 description 27
- 230000008859 change Effects 0.000 description 26
- 210000004027 cell Anatomy 0.000 description 25
- 230000006378 damage Effects 0.000 description 23
- 229910052751 metal Inorganic materials 0.000 description 21
- 239000002184 metal Substances 0.000 description 21
- 230000004044 response Effects 0.000 description 21
- 239000000523 sample Substances 0.000 description 20
- 238000012545 processing Methods 0.000 description 19
- 230000005540 biological transmission Effects 0.000 description 18
- 206010036618 Premenstrual syndrome Diseases 0.000 description 17
- 238000013461 design Methods 0.000 description 17
- 230000000737 periodic effect Effects 0.000 description 17
- 238000002604 ultrasonography Methods 0.000 description 17
- 238000006243 chemical reaction Methods 0.000 description 16
- 239000003990 capacitor Substances 0.000 description 15
- 230000001360 synchronised effect Effects 0.000 description 15
- 230000001225 therapeutic effect Effects 0.000 description 15
- 230000009286 beneficial effect Effects 0.000 description 14
- 238000002653 magnetic therapy Methods 0.000 description 14
- 239000000203 mixture Substances 0.000 description 14
- 230000003287 optical effect Effects 0.000 description 14
- 230000002093 peripheral effect Effects 0.000 description 13
- 230000002829 reductive effect Effects 0.000 description 13
- 230000001413 cellular effect Effects 0.000 description 12
- 239000011159 matrix material Substances 0.000 description 12
- 102000000634 Cytochrome c oxidase subunit IV Human genes 0.000 description 11
- 108090000365 Cytochrome-c oxidases Proteins 0.000 description 11
- 208000027418 Wounds and injury Diseases 0.000 description 11
- 230000008901 benefit Effects 0.000 description 11
- 239000000872 buffer Substances 0.000 description 11
- 238000010276 construction Methods 0.000 description 11
- 230000001965 increasing effect Effects 0.000 description 11
- 150000003071 polychlorinated biphenyls Chemical class 0.000 description 11
- 210000004556 brain Anatomy 0.000 description 10
- 239000003925 fat Substances 0.000 description 10
- 238000013021 overheating Methods 0.000 description 10
- 238000000015 thermotherapy Methods 0.000 description 10
- 238000012384 transportation and delivery Methods 0.000 description 10
- 206010061218 Inflammation Diseases 0.000 description 9
- 239000003814 drug Substances 0.000 description 9
- 230000005284 excitation Effects 0.000 description 9
- 230000035876 healing Effects 0.000 description 9
- 230000004054 inflammatory process Effects 0.000 description 9
- 230000003239 periodontal effect Effects 0.000 description 9
- 230000032258 transport Effects 0.000 description 9
- 238000010521 absorption reaction Methods 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 238000004364 calculation method Methods 0.000 description 8
- 239000000470 constituent Substances 0.000 description 8
- 230000003292 diminished effect Effects 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 208000014674 injury Diseases 0.000 description 8
- 238000003860 storage Methods 0.000 description 8
- 230000007704 transition Effects 0.000 description 8
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 7
- 230000004913 activation Effects 0.000 description 7
- 238000009826 distribution Methods 0.000 description 7
- 208000015181 infectious disease Diseases 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 238000010200 validation analysis Methods 0.000 description 7
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 6
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 6
- 238000013459 approach Methods 0.000 description 6
- 230000003190 augmentative effect Effects 0.000 description 6
- 238000013475 authorization Methods 0.000 description 6
- XAEWZDYWZHIUCT-UHFFFAOYSA-N desipramine hydrochloride Chemical compound [H+].[Cl-].C1CC2=CC=CC=C2N(CCCNC)C2=CC=CC=C21 XAEWZDYWZHIUCT-UHFFFAOYSA-N 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- 238000005286 illumination Methods 0.000 description 6
- 230000000670 limiting effect Effects 0.000 description 6
- 229910001416 lithium ion Inorganic materials 0.000 description 6
- 230000000638 stimulation Effects 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- XTWYTFMLZFPYCI-UHFFFAOYSA-N Adenosine diphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(O)=O)C(O)C1O XTWYTFMLZFPYCI-UHFFFAOYSA-N 0.000 description 5
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 5
- 102000001554 Hemoglobins Human genes 0.000 description 5
- 108010054147 Hemoglobins Proteins 0.000 description 5
- 101000583145 Homo sapiens Membrane-associated phosphatidylinositol transfer protein 1 Proteins 0.000 description 5
- 101000583150 Homo sapiens Membrane-associated phosphatidylinositol transfer protein 3 Proteins 0.000 description 5
- HBBGRARXTFLTSG-UHFFFAOYSA-N Lithium ion Chemical compound [Li+] HBBGRARXTFLTSG-UHFFFAOYSA-N 0.000 description 5
- 102100030353 Membrane-associated phosphatidylinositol transfer protein 1 Human genes 0.000 description 5
- 102100030351 Membrane-associated phosphatidylinositol transfer protein 3 Human genes 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- DZSYJVXGONVNKA-UHFFFAOYSA-L NIR-1 dye Chemical compound [K+].[K+].C1=CC2=C(S([O-])(=O)=O)C=C(S([O-])(=O)=O)C=C2C(C2(C)C)=C1[N+](CC)=C2C=CC=CC=CC=C1C(C)(C)C2=CC(C(O)=O)=CC=C2N1CCCCS([O-])(=O)=O DZSYJVXGONVNKA-UHFFFAOYSA-L 0.000 description 5
- AUQMGYLQQPSCNH-UHFFFAOYSA-L NIR-2 dye Chemical compound [K+].[K+].C1=CC2=C(S([O-])(=O)=O)C=C(S([O-])(=O)=O)C=C2C(C2(C)C)=C1[N+](CC)=C2C=CC=CC=C1C(C)(C)C2=CC(C(O)=O)=CC=C2N1CCCCS([O-])(=O)=O AUQMGYLQQPSCNH-UHFFFAOYSA-L 0.000 description 5
- 230000009471 action Effects 0.000 description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- 230000033228 biological regulation Effects 0.000 description 5
- 230000001427 coherent effect Effects 0.000 description 5
- 230000001276 controlling effect Effects 0.000 description 5
- 229910052802 copper Inorganic materials 0.000 description 5
- 239000010949 copper Substances 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 238000013507 mapping Methods 0.000 description 5
- 210000003470 mitochondria Anatomy 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 210000000056 organ Anatomy 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- 238000013139 quantization Methods 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 239000004065 semiconductor Substances 0.000 description 5
- 230000009466 transformation Effects 0.000 description 5
- XTWYTFMLZFPYCI-KQYNXXCUSA-N 5'-adenylphosphoric acid Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XTWYTFMLZFPYCI-KQYNXXCUSA-N 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 238000001467 acupuncture Methods 0.000 description 4
- 230000002051 biphasic effect Effects 0.000 description 4
- 239000011449 brick Substances 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 229920005994 diacetyl cellulose Polymers 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 238000004880 explosion Methods 0.000 description 4
- 229920005570 flexible polymer Polymers 0.000 description 4
- 238000011068 loading method Methods 0.000 description 4
- 230000007257 malfunction Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000035515 penetration Effects 0.000 description 4
- 230000000258 photobiological effect Effects 0.000 description 4
- 238000003825 pressing Methods 0.000 description 4
- 230000000630 rising effect Effects 0.000 description 4
- 231100000241 scar Toxicity 0.000 description 4
- 229910000679 solder Inorganic materials 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 230000003068 static effect Effects 0.000 description 4
- 238000001308 synthesis method Methods 0.000 description 4
- 238000012935 Averaging Methods 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 206010052428 Wound Diseases 0.000 description 3
- 238000002679 ablation Methods 0.000 description 3
- 238000000862 absorption spectrum Methods 0.000 description 3
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 3
- 238000003491 array Methods 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 238000012937 correction Methods 0.000 description 3
- 238000013500 data storage Methods 0.000 description 3
- 230000009977 dual effect Effects 0.000 description 3
- 210000005069 ears Anatomy 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 230000004907 flux Effects 0.000 description 3
- 238000003384 imaging method Methods 0.000 description 3
- 238000002329 infrared spectrum Methods 0.000 description 3
- 230000000977 initiatory effect Effects 0.000 description 3
- 239000012212 insulator Substances 0.000 description 3
- 238000009196 low level laser therapy Methods 0.000 description 3
- 238000007620 mathematical function Methods 0.000 description 3
- 230000010355 oscillation Effects 0.000 description 3
- 244000045947 parasite Species 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- 238000002428 photodynamic therapy Methods 0.000 description 3
- 229920001296 polysiloxane Polymers 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- 230000003595 spectral effect Effects 0.000 description 3
- 230000036962 time dependent Effects 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 2
- 201000004569 Blindness Diseases 0.000 description 2
- 208000007333 Brain Concussion Diseases 0.000 description 2
- 101100518633 Caenorhabditis elegans dpy-18 gene Proteins 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- UDMBCSSLTHHNCD-UHFFFAOYSA-N Coenzym Q(11) Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1O UDMBCSSLTHHNCD-UHFFFAOYSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 208000007101 Muscle Cramp Diseases 0.000 description 2
- 208000000112 Myalgia Diseases 0.000 description 2
- 206010057249 Phagocytosis Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- LNQVTSROQXJCDD-UHFFFAOYSA-N adenosine monophosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)C(OP(O)(O)=O)C1O LNQVTSROQXJCDD-UHFFFAOYSA-N 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 230000009514 concussion Effects 0.000 description 2
- 238000012885 constant function Methods 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 231100000673 dose–response relationship Toxicity 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000001827 electrotherapy Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000000981 epithelium Anatomy 0.000 description 2
- 239000000446 fuel Substances 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000009434 installation Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 238000002647 laser therapy Methods 0.000 description 2
- 238000012886 linear function Methods 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 230000005389 magnetism Effects 0.000 description 2
- 238000007726 management method Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000010534 mechanism of action Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000036640 muscle relaxation Effects 0.000 description 2
- 210000001328 optic nerve Anatomy 0.000 description 2
- 238000005192 partition Methods 0.000 description 2
- 208000028169 periodontal disease Diseases 0.000 description 2
- 230000008782 phagocytosis Effects 0.000 description 2
- 230000010363 phase shift Effects 0.000 description 2
- 230000029553 photosynthesis Effects 0.000 description 2
- 238000010672 photosynthesis Methods 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 238000005476 soldering Methods 0.000 description 2
- 210000000130 stem cell Anatomy 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- 230000014616 translation Effects 0.000 description 2
- 230000024883 vasodilation Effects 0.000 description 2
- 238000001429 visible spectrum Methods 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- BSFODEXXVBBYOC-UHFFFAOYSA-N 8-[4-(dimethylamino)butan-2-ylamino]quinolin-6-ol Chemical compound C1=CN=C2C(NC(CCN(C)C)C)=CC(O)=CC2=C1 BSFODEXXVBBYOC-UHFFFAOYSA-N 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010006811 Bursitis Diseases 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 241001536817 Clarkus Species 0.000 description 1
- 102100030497 Cytochrome c Human genes 0.000 description 1
- 108010075031 Cytochromes c Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 240000004272 Eragrostis cilianensis Species 0.000 description 1
- 208000001640 Fibromyalgia Diseases 0.000 description 1
- 229910005542 GaSb Inorganic materials 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 229910000673 Indium arsenide Inorganic materials 0.000 description 1
- 206010023230 Joint stiffness Diseases 0.000 description 1
- 208000034693 Laceration Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241000219823 Medicago Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 101710129178 Outer plastidial membrane protein porin Proteins 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 206010063493 Premature ageing Diseases 0.000 description 1
- 208000032038 Premature aging Diseases 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 102100037820 Voltage-dependent anion-selective channel protein 1 Human genes 0.000 description 1
- 230000036982 action potential Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 210000003423 ankle Anatomy 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 238000012550 audit Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000007175 bidirectional communication Effects 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- -1 blood pressure Substances 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 210000000133 brain stem Anatomy 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 230000027288 circadian rhythm Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000001149 cognitive effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000008094 contradictory effect Effects 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 238000011549 displacement method Methods 0.000 description 1
- 230000009189 diving Effects 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000006397 emotional response Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 238000001413 far-infrared spectroscopy Methods 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000010304 firing Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 208000024693 gingival disease Diseases 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 231100000652 hormesis Toxicity 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000003116 impacting effect Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- RPQDHPTXJYYUPQ-UHFFFAOYSA-N indium arsenide Chemical compound [In]#[As] RPQDHPTXJYYUPQ-UHFFFAOYSA-N 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000005061 intracellular organelle Anatomy 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 238000012804 iterative process Methods 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000008338 local blood flow Effects 0.000 description 1
- 231100000516 lung damage Toxicity 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 239000000696 magnetic material Substances 0.000 description 1
- 238000002595 magnetic resonance imaging Methods 0.000 description 1
- 230000031852 maintenance of location in cell Effects 0.000 description 1
- 238000002078 massotherapy Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 208000013465 muscle pain Diseases 0.000 description 1
- 210000002346 musculoskeletal system Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000006855 networking Effects 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 230000007604 neuronal communication Effects 0.000 description 1
- 238000001208 nuclear magnetic resonance pulse sequence Methods 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 238000011275 oncology therapy Methods 0.000 description 1
- 238000011369 optimal treatment Methods 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000013610 patient sample Substances 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 210000000578 peripheral nerve Anatomy 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000008832 photodamage Effects 0.000 description 1
- 230000001443 photoexcitation Effects 0.000 description 1
- 230000016732 phototransduction Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 230000036316 preload Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000003134 recirculating effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 230000004043 responsiveness Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 238000011076 safety test Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000011450 sequencing therapy Methods 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 230000036620 skin dryness Effects 0.000 description 1
- 210000003625 skull Anatomy 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- UGODCLHJOJPPHP-AZGWGOJFSA-J tetralithium;[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-4-hydroxy-2-[[oxido(sulfonatooxy)phosphoryl]oxymethyl]oxolan-3-yl] phosphate;hydrate Chemical compound [Li+].[Li+].[Li+].[Li+].O.C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OS([O-])(=O)=O)[C@@H](OP([O-])([O-])=O)[C@H]1O UGODCLHJOJPPHP-AZGWGOJFSA-J 0.000 description 1
- 238000011287 therapeutic dose Methods 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000003039 volatile agent Substances 0.000 description 1
- 230000005428 wave function Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 229910000859 α-Fe Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0601—Apparatus for use inside the body
- A61N5/0603—Apparatus for use inside the body for treatment of body cavities
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/02—Magnetotherapy using magnetic fields produced by coils, including single turn loops or electromagnets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0622—Optical stimulation for exciting neural tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0625—Warming the body, e.g. hyperthermia treatment
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/40—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/40—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the management of medical equipment or devices, e.g. scheduling maintenance or upgrades
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0601—Apparatus for use inside the body
- A61N5/0603—Apparatus for use inside the body for treatment of body cavities
- A61N2005/0606—Mouth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0626—Monitoring, verifying, controlling systems and methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
- A61N2005/0643—Applicators, probes irradiating specific body areas in close proximity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
- A61N2005/0643—Applicators, probes irradiating specific body areas in close proximity
- A61N2005/0644—Handheld applicators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/065—Light sources therefor
- A61N2005/0651—Diodes
- A61N2005/0652—Arrays of diodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/067—Radiation therapy using light using laser light
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Radiology & Medical Imaging (AREA)
- Veterinary Medicine (AREA)
- Pathology (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Primary Health Care (AREA)
- General Business, Economics & Management (AREA)
- Business, Economics & Management (AREA)
- Urology & Nephrology (AREA)
- Surgery (AREA)
- Biophysics (AREA)
- Neurosurgery (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Radiation-Therapy Devices (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Confectionery (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862653846P | 2018-04-06 | 2018-04-06 | |
| PCT/US2019/026222 WO2019195816A1 (en) | 2018-04-06 | 2019-04-06 | Distributed photobiomodulation therapy system and method |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| ES2788140A2 ES2788140A2 (es) | 2020-10-20 |
| ES2788140R1 ES2788140R1 (es) | 2021-09-14 |
| ES2788140B2 true ES2788140B2 (es) | 2023-03-24 |
Family
ID=68101298
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES202090046A Active ES2788140B2 (es) | 2018-04-06 | 2019-04-06 | Terapia de fotobiomodulacion distribuida, sistema y metodo |
Country Status (12)
| Country | Link |
|---|---|
| JP (1) | JP2021520867A (ko) |
| KR (1) | KR20210005616A (ko) |
| CN (1) | CN112996559B (ko) |
| CL (1) | CL2020002581A1 (ko) |
| ES (1) | ES2788140B2 (ko) |
| IL (1) | IL277775B2 (ko) |
| MX (1) | MX2020010553A (ko) |
| PE (1) | PE20210544A1 (ko) |
| SG (1) | SG11202009869RA (ko) |
| TW (1) | TWI787493B (ko) |
| WO (1) | WO2019195816A1 (ko) |
| ZA (1) | ZA202006175B (ko) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2023507975A (ja) * | 2019-12-20 | 2023-02-28 | シャント テクノロジーズ， インコーポレイテッド | 移動リアルタイム位置測位ユニット |
| CN115243758A (zh) * | 2020-04-03 | 2022-10-25 | 刘·利沐 | 用于提高免疫力和治疗呼吸道感染的光生物调节系统和方法 |
| CN111729203B (zh) * | 2020-06-11 | 2022-02-15 | 中国人民解放军军事科学院国防科技创新研究院 | 一种用于降低成瘾和冒进的装置 |
| US11464997B2 (en) | 2020-07-18 | 2022-10-11 | Konrad Jarausch | Systems and methods for light generation and use thereof |
| WO2023283164A1 (en) * | 2021-07-06 | 2023-01-12 | Biolight, Inc. | Oral guard for light therapy |
| AU2022358750A1 (en) * | 2021-10-08 | 2024-05-16 | Octane Innovation Inc. | Personalized bioelectromagnetic therapeutics |
| WO2023228206A1 (en) * | 2022-05-25 | 2023-11-30 | Litemed India Private Limited | Musculoskeletal pain reliever for acute and chronic pain |
| CN115526303B (zh) * | 2022-09-15 | 2023-09-26 | 常州大学 | 一种简单非自治可控多涡卷的神经元电路 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5259380A (en) * | 1987-11-04 | 1993-11-09 | Amcor Electronics, Ltd. | Light therapy system |
| US6720745B2 (en) * | 1997-08-26 | 2004-04-13 | Color Kinetics, Incorporated | Data delivery track |
| RU2145247C1 (ru) * | 1998-04-10 | 2000-02-10 | Жаров Владимир Павлович | Фотоматричное терапевтическое устройство для лечения протяженных патологий |
| US6663659B2 (en) * | 2000-01-13 | 2003-12-16 | Mcdaniel David H. | Method and apparatus for the photomodulation of living cells |
| US20020143373A1 (en) * | 2001-01-25 | 2002-10-03 | Courtnage Peter A. | System and method for therapeutic application of energy |
| US7150710B2 (en) * | 2001-06-26 | 2006-12-19 | Photomed Technologies, Inc. | Therapeutic methods using electromagnetic radiation |
| US20070219604A1 (en) * | 2006-03-20 | 2007-09-20 | Palomar Medical Technologies, Inc. | Treatment of tissue with radiant energy |
| WO2014018103A1 (en) * | 2012-07-26 | 2014-01-30 | Brezinski Donna J | Portable phototherapy device |
| US10328276B2 (en) * | 2014-02-14 | 2019-06-25 | Applied Biophotonics Ltd. | Sinusoidal drive system and method for phototherapy |
| US9877361B2 (en) * | 2012-11-08 | 2018-01-23 | Applied Biophotonics Ltd | Phototherapy system and process including dynamic LED driver with programmable waveform |
| US9895550B2 (en) * | 2014-01-23 | 2018-02-20 | Applied Biophotonics Ltd | Flexible LED light pad for phototherapy |
| KR20170023776A (ko) * | 2014-02-26 | 2017-03-06 | 루마 세러퓨틱스 인코포레이티드 | 자외선 광선 치료 장치들 및 방법들 |
| WO2016007798A2 (en) * | 2014-07-09 | 2016-01-14 | Akari Systems, Inc. | Wearable therapeutic light source |
-
2019
- 2019-04-06 JP JP2020554839A patent/JP2021520867A/ja active Pending
- 2019-04-06 WO PCT/US2019/026222 patent/WO2019195816A1/en active Application Filing
- 2019-04-06 CN CN201980038356.5A patent/CN112996559B/zh active Active
- 2019-04-06 MX MX2020010553A patent/MX2020010553A/es unknown
- 2019-04-06 KR KR1020207031866A patent/KR20210005616A/ko not_active Application Discontinuation
- 2019-04-06 ES ES202090046A patent/ES2788140B2/es active Active
- 2019-04-06 PE PE2020001545A patent/PE20210544A1/es unknown
- 2019-04-06 SG SG11202009869RA patent/SG11202009869RA/en unknown
- 2019-04-06 IL IL277775A patent/IL277775B2/en unknown
- 2019-04-08 TW TW108112192A patent/TWI787493B/zh active
-
2020
- 2020-10-05 ZA ZA2020/06175A patent/ZA202006175B/en unknown
- 2020-10-06 CL CL2020002581A patent/CL2020002581A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN112996559A (zh) | 2021-06-18 |
| ZA202006175B (en) | 2022-02-23 |
| SG11202009869RA (en) | 2020-11-27 |
| MX2020010553A (es) | 2021-03-25 |
| IL277775B1 (en) | 2024-03-01 |
| CL2020002581A1 (es) | 2021-05-14 |
| WO2019195816A1 (en) | 2019-10-10 |
| ES2788140A2 (es) | 2020-10-20 |
| IL277775A (en) | 2020-11-30 |
| TWI787493B (zh) | 2022-12-21 |
| TW201944430A (zh) | 2019-11-16 |
| CN112996559B (zh) | 2023-11-21 |
| PE20210544A1 (es) | 2021-03-17 |
| KR20210005616A (ko) | 2021-01-14 |
| IL277775B2 (en) | 2024-07-01 |
| JP2021520867A (ja) | 2021-08-26 |
| ES2788140R1 (es) | 2021-09-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2788140B2 (es) | Terapia de fotobiomodulacion distribuida, sistema y metodo | |
| US12035433B2 (en) | Distributed photobiomodulation therapy system and method | |
| JP2021520867A5 (ko) | ||
| US11006488B2 (en) | Phototherapy process including dynamic LED driver with programmable waveform | |
| US20190335551A1 (en) | Distributed Photobiomodulation Therapy Devices And Methods, Biofeedback, And Communication Protocols Therefor | |
| JP6659587B2 (ja) | 光線治療のための正弦波駆動システム及び方法 | |
| US20130304019A1 (en) | Photodynamic therapy system, device and associated method of treatment | |
| US20150209597A1 (en) | Phototherapy eyeglass device | |
| KR20120131316A (ko) | 색광 치료기 | |
| CN110393863A (zh) | 一种光波理疗电极贴 | |
| KR20200055055A (ko) | 전자기파 전송 장치 | |
| KR20200136270A (ko) | 손목 질병 치료 장치 | |
| US11517706B2 (en) | Functional electrical stimulation device for reducing preoperative and prenatal anxiety and method for using same | |
| CN211327808U (zh) | 一种光波理疗电极贴 | |
| KR102215654B1 (ko) | 복합 치료 장치 | |
| WO2024066468A1 (zh) | 便携式美容仪 | |
| RU56197U1 (ru) | Физиотерапевтический аппарат для свето- и цветотерапии | |
| US20230355095A1 (en) | Treatment chair | |
| US20230355090A1 (en) | Smart eye mask | |
| MX2009009938A (es) | Regulador biofisiologico para tratamientos terapeuticos. | |
| ES1238104U (es) | Aparato de biorresonancia | |
| LT6109B (lt) | Kompleksinio terapinio poveikio prietaisas gydant diabetą | |
| TWM438287U (en) | Multi-spectra device |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BA2A | Patent application published |
Ref document number: 2788140 Country of ref document: ES Kind code of ref document: A2 Effective date: 20201020 |
|
| FG2A | Definitive protection |
Ref document number: 2788140 Country of ref document: ES Kind code of ref document: B2 Effective date: 20230324 |